Posted by Michael Wonder on 12 Aug 2021
Australian Technical Advisory Group on Immunisation weekly COVID-19 meeting - 11 August 2021 update
12 August 2021 - ATAGI met on Wednesday 11 August 2021 to review the latest developments relating to adverse events observed following immunisation with COVID-19 vaccines, including AstraZeneca COVID-19 vaccine and thrombosis and thrombocytopenia syndrome cases in Australia.
ATAGI examined estimates of risk of thrombosis and thrombocytopenia syndrome by age group in Australia and note that there have been 104 cases of confirmed or probable thrombosis and thrombocytopenia syndrome (59 confirmed cases; 45 probable cases).
To date around 7.4 million doses of COVID-19 Vaccine AstraZeneca have been administered.
